CN113005104B - Thallus laminariae disaccharide phosphorylase mutant with improved heat stability and application thereof - Google Patents

Thallus laminariae disaccharide phosphorylase mutant with improved heat stability and application thereof Download PDF

Info

Publication number
CN113005104B
CN113005104B CN201911329886.3A CN201911329886A CN113005104B CN 113005104 B CN113005104 B CN 113005104B CN 201911329886 A CN201911329886 A CN 201911329886A CN 113005104 B CN113005104 B CN 113005104B
Authority
CN
China
Prior art keywords
gly
leu
ala
glu
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911329886.3A
Other languages
Chinese (zh)
Other versions
CN113005104A (en
Inventor
游淳
孙尚尚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Institute of Industrial Biotechnology of CAS
Original Assignee
Tianjin Institute of Industrial Biotechnology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Institute of Industrial Biotechnology of CAS filed Critical Tianjin Institute of Industrial Biotechnology of CAS
Priority to CN201911329886.3A priority Critical patent/CN113005104B/en
Publication of CN113005104A publication Critical patent/CN113005104A/en
Application granted granted Critical
Publication of CN113005104B publication Critical patent/CN113005104B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/12Disaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/01Hexosyltransferases (2.4.1)
    • C12Y204/01031Laminaribiose phosphorylase (2.4.1.31)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention discloses a laminarin phosphorylase mutant with improved thermal stability and application thereof in high-temperature synthesis of laminarin, belonging to the technical field of enzyme engineering. The laminaria disaccharide phosphorylase mutant with obviously improved thermal stability disclosed by the invention is obtained by establishing a gene mutation library by a site-directed saturation mutation and random mutation method based on laminaria disaccharide phosphorylase from pseudomonas sp.YM1 and screening the gene mutation library. And then the obtained laminarin phosphorylase mutant is used for constructing an in-vitro multienzyme system, and laminarin is prepared by taking starch as a substrate at high temperature. Compared with the wild type, the mutant has obviously improved thermal stability, can ensure that the enzyme activity is not lost in the process production high temperature link, replaces the wild type of laminaria disaccharide phosphorylase to be applied to synthesizing laminaria disaccharide at high temperature, can improve the reaction rate of the whole in-vitro multienzyme system, shortens the reaction time, and further improves the industrialization potential of laminaria disaccharide.

Description

Thallus laminariae disaccharide phosphorylase mutant with improved heat stability and application thereof
Technical Field
The invention belongs to the technical field of enzyme engineering, and particularly relates to a laminarin phosphorylase mutant and application thereof in high-temperature synthesis of laminarin.
Background
Laminarin (laminarin) is a reducing disaccharide linked by beta-1, 3 glycosidic bonds, and is a high-valence oligosaccharide with various functions. The hyaluronic acid can be used as a synthetic precursor of hyaluronic acid in pharmaceutical and cosmetic industries, used as a germination promoter and a natural preservative in the agricultural field, used as a food additive in the food health care product industry, and also used for regulating and controlling protein expression of thermophilic bacteria such as clostridium thermocellum. The traditional preparation method of laminarin disaccharide is acidolysis or enzymolysis of beta-1, 3-polysaccharide, such as laminarin, pachyman, lichenan and curdlan, but the natural polysaccharide raw materials are limited in supply, the hydrolysis process is difficult to control, the product separation step is complicated, and the production cost of laminarin disaccharide is high. With the development of industrial enzyme biotechnology, scientists have begun to attempt enzymatic synthesis of laminariae disaccharide. The domestic scholars tried to produce laminariae disaccharide using 3 enzymes (starch phosphorylase, glucosidase and laminaria disaccharide phosphorylase) with starch as substrate, and the conversion rate of about 80% could be reached by reacting for 12 hours at 50 ℃, however the poor thermal stability of laminaria disaccharide phosphorylase limited its application at temperatures above 50 ℃.
Laminarin phosphorylase (laminaribiose phosphorylase, LBP, EC 2.4.1.31) is a phosphorylase belonging to the family of glycoside hydrolases 94, which can reversibly catalyze laminarin to glucose 1-phosphate and glucose. Laminarin phosphorylase was first found in the Roman snail (Helixpoint), but pure enzyme was not isolated. Subsequently, 4 different sources of laminarin phosphorylases were identified successively, derived from euglena (euglena), metamorphic algae (Astasia ocellata), cholesterolfree (Acholeplasma laidlawii) and pseudomonas (Paenibacillus sp.). Wherein the laminaria disaccharide phosphorylase from euglena, metamorphic algae and cholesterolfree pathogen is mesophilic enzyme, and the optimum temperature is 30-40 ℃; the optimum temperature of laminaria disaccharide phosphorylase from pseudomonas is 55 ℃, but the thermal stability is poor, the half-life of pure enzyme solution is only about 10min after being treated at 60 ℃, and the laminaria disaccharide phosphorylase is not suitable for the industrial mass production of laminaria disaccharide by an in vitro biosynthesis system.
In order to promote the industrial application of laminarin phosphorylase in laminarin, a laminarin phosphorylase mutant with improved thermal stability is needed, which can ensure that the enzyme activity is not lost in the high-temperature link of the process production and keep the high specific enzyme activity.
Disclosure of Invention
The technical problem to be solved by the invention is to provide laminaria disaccharide phosphorylase with improved thermal stability, and apply the laminaria disaccharide phosphorylase to an in-vitro multienzyme system for producing laminaria disaccharide by using starch as a substrate to catalyze, thereby achieving the purpose of synthesizing laminaria disaccharide with high temperature and high conversion rate and high efficiency.
In order to solve the technical problems, the invention adopts the following technical scheme:
step 1: analyzing the crystal structure of laminaria disaccharide phosphorylase from pseudomonas by using calculation software to determine mutation site;
step 2: respectively carrying out saturation mutation library construction screening on the mutation sites in the step 1;
step 3: performing expression purification on the positive clone obtained after the preliminary screening in the step 2, and measuring the thermal stability;
step 4: taking the most outstanding site with improved thermal stability obtained by re-screening in the step 3 as an initial sequence, and carrying out iterative saturation mutation on other sites;
step 5: carrying out random mutation library construction screening on the mutant sequence finally screened in the step 4, and further improving the thermal stability of laminaria disaccharide phosphorylase;
step 6: and (3) using the mutant finally screened in the step (5) as a system for preparing laminaria disaccharide by using starch as a substrate and catalyzing with multiple enzymes, reacting at 60 ℃ for 8 hours, and comparing the generation conditions of wild type laminaria disaccharide and mutant laminaria disaccharide.
In order to develop laminaria disaccharide phosphorylase (LBP for short herein) with high thermal stability, the invention is based on laminaria disaccharide phosphorylase (Genebank: BAJ10826, SEQ ID NO: 1) derived from pseudomonas sp.YM1, establishes an LBP gene mutation library by a site-directed saturation mutation and error-prone PCR method, and obtains LBP mutants with obviously improved thermal stability by screening the gene mutation library.
The invention provides an enzyme mutant, the amino acid sequence of the enzyme is SEQ ID NO.2, which is a mutant that the 11 th E of SEQ ID NO.1 is replaced by I and the 12 th Q is replaced by V.
The invention provides an enzyme mutant, the amino acid sequence of the enzyme is SEQ ID NO.3, and the amino acid sequence is replaced by N at 171 th position D of SEQ ID NO. 2.
The invention provides an enzyme mutant, the amino acid sequence of the enzyme is SEQ ID NO.4, and the amino acid sequence is F instead of C at 877 of SEQ ID NO. 3.
The invention provides an enzyme mutant, the amino acid sequence of the enzyme is SEQ ID NO.5, and the amino acid sequence is that D at 452 of SEQ ID NO.4 is replaced by G.
The invention provides an enzyme mutant, the amino acid sequence of the enzyme is SEQ ID NO.6, and the L at the 26 th position of SEQ ID NO.5 is replaced by Q.
The invention provides an enzyme mutant, the amino acid sequence of the enzyme is SEQ ID NO.7, and the I of the 186 th position of SEQ ID NO.6 is replaced by T.
Compared with the prior art, the technical scheme of the invention has the following beneficial effects:
compared with wild type LBP, the LBP enzyme mutant obtained by the invention has the half-life of the mutant at 60 ℃ increased from 10min to 9.76h, which is increased by 58.6 times at most, and the specific enzyme activity is equivalent to that of the wild type; the half-life of the mutant at 65 ℃ is improved from 2min to 3.11h, which is improved by 93.3 times at most.
Drawings
FIG. 1 shows the results of semi-rational design mutation of LBP, 60℃half-life assay.
FIG. 2 shows the result of random mutation of LBP, half-life at 65 ℃.
FIG. 3 shows the LBP mutation site alignment analysis.
FIG. 4 is a schematic representation of the in vitro multienzyme catalytic pathway for starch conversion to laminariae disaccharide; wherein: IA is isoamylase, αgp is starch phosphorylase, αg is glucosidase, and LBP is laminaria disaccharide phosphorylase.
FIG. 5 shows the high temperature synthesis of laminariae disaccharide from 10g/L IA treated starch catalyzed by multiple enzymes in vitro.
Detailed Description
The invention will be further described with reference to specific embodiments, and advantages and features of the invention will become apparent from the description. It should be understood that the embodiments described are exemplary only and should not be construed as limiting the scope of the invention in any way. It will be understood by those skilled in the art that various changes and substitutions can be made in the details and form of the technical solution of the present invention without departing from the spirit and scope of the invention, but these changes and substitutions fall within the scope of the present invention.
The following materials were used in the examples of the present invention
Soluble starch, ACROS company product, product number: 424490020;
pET28a vector, novagen, madison, wis;
coli expressing strain BL21 (DE 3), invitrogen, carlsbad, calif.;
all enzymes of the invention are commercially available from Sigma, and all enzymes are also obtained by prokaryotic expression according to genetic engineering methods.
The method for measuring laminaria disaccharide comprises the following steps:
high Performance Liquid Chromatography (HPLC) detection method: RID detector, HPX-87H column (Bio-Rad Hercules, calif.), mobile phase: 5mM H2SO4, flow rate 0.6mL/min, column temperature 55℃and sample volume 20. Mu.L.
Culture medium (g/L): tryptone 10, yeast powder 5 and NaCl 10.
The screening method comprises the following steps: screening was performed by a plate colony cover two-plate chromogenic method, and 8mL of a 0.5% (w/v) thawed agarose solution (60 ℃) containing 50mM HEPESbuffer (pH 7.0), 2mM laminabiose, 2mM phosphate ion, 4mM magnesium ion, 0.5mM NAD+, 50. Mu.M tetranitroblue tetrazolium (TNBT), 10. Mu.M Phenazine Methosulfate (PMS), 1U/mL glucose mutase Phosphate (PGM), 1U/mL glucose 6-phosphate dehydrogenase (G6 PDH) was carefully poured onto the heat-treated plate colony. After 30 minutes at room temperature, positive colonies will appear as blue-black halos.
Example 1 rational analysis, determination of mutation sites
The LBP of Pseudomonas is a homodimer, the catalytic pocket is located in the binding region on both monomers and its crystal structure has been published (PDB: 6gh 2). The optimal temperature of the pure enzyme is 55 ℃, the half life period at 60 ℃ is 10min, the crystal structure of the PDB from pseudomonas LBP is calculated and analyzed by adopting B-FITER and ETSS software respectively, and E11, Q12, D171 and C877 are determined as possible sites for improving the thermal stability.
Site-directed saturation mutagenesis was performed using the rapid PCR technique, with plasmid pET20b-LBP expressing the wild-type LBP gene as template.
Primer for introducing E11 and Q12 mutations:
forward primer: GGTNNKNNKGGTGAATTTCGTCTGGAACAGCCGGAAC
Reverse primer: CTGAAATTTCCAGCCTTTCTGACCCATGGTATATC
Primer for introducing D171 mutation:
forward primer: GTCGTAGTGCCNNKGATCTGCGTGATCATC
Reverse primer: CATACAGCGGAATTGCGGCGGTAGG
Primer for introducing C877 mutation:
forward primer: GCCAGAGCGTGGATNNKCAGAATGATGGC
Reverse primer: CATTCAGACTAACGCTATCAACACGATACTGGCC
Primer phosphorylation system: NEB T4 PNK buffer 2. Mu.L, ATP (100 mM) 1. Mu.L, NEB T4 PNK 1. Mu.L, primer (100. Mu.M) 2. Mu.L, and double distilled water 14. Mu.L were added.
The PCR reaction system is as follows: 10. Mu.L of buffer, 4. Mu.L of dNTPs (2.5 mM each), 1. Mu.L of phosphorylated forward primer (10. Mu.M), 1. Mu.L of phosphorylated reverse primer (10. Mu.M), 1. Mu.L of template DNA, 0.5. Mu.L of NEB high-fidelity Q5 DNApolymerase (2.5U/. Mu.L), and 32.5. Mu.L of double distilled water were added.
The PCR amplification conditions are as follows: pre-denaturation at 98℃for 2min; then, 30 cycles were performed at 98℃for 10s,55℃for 15s, and 72℃for 2min, and finally, the temperature was kept at 72℃for 5min.
After the PCR product is digested for 0.5h by Dpn I, the PCR product is purified by TIAN quickMidipurification kit (Tiangen, beijin, china), the NEB Quick Ligation kit is used for connecting linear plasmids into a ring shape, the linear plasmids are respectively transferred into competent cells of E.coli TOP10, the competent cells are coated into LB solid medium containing agar for culturing overnight, the flat plate is subjected to heat treatment at 60 ℃ for 1h, a chromogenic two-layer flat plate is covered, positive clones are selected, plasmids are extracted, the competent cells are transferred into competent cells of E.coli BL21 (DE 3), enzyme expression and purification are carried out, and the thermal stability of the enzyme is measured.
Screening gave E11I Q V mutant (i.e.mutant M1), which had the most significant improvement in thermostability over the wild type, increasing the half-life of LBP pure enzyme at 60℃from 10min to 1.56h (FIG. 2).
The rapid PCR technique was used to carry out saturation mutation at D177 and C877 sites using plasmid pET20b-lbpm1 expressing the gene of mutant LBP-M1 as a template, and the obtained mutant M2 (E11I Q12VD 171N) was selected to increase the half-life of LBP pure enzyme at 60℃to 2.59h (FIG. 2).
The saturated mutation at the C877 site was performed using the plasmid pET20b-lbpm2 expressing the gene of the mutant LBP-M2 as a template by the rapid PCR technique, and the obtained mutant M3 (E11I Q12V D171N C877F) was selected to increase the half-life of the LBP pure enzyme to 3.46h at 60 ℃.
EXAMPLE 2 random mutagenesis further improves thermostability
Through computational analysis and iterative saturation mutation, the thermal stability of LBP from pseudomonas at 60 ℃ is obviously improved, and random mutation is adopted for library construction and screening so as to obtain mutants with better thermal stability.
Random mutation was performed using error-prone PCR technique with plasmid pET20b-lbpm3 expressing the gene of mutant LBP-M3 as template.
The method for building the library comprises the following steps:
the lbp gene fragment is amplified by adopting error-prone PCR technology and using pET20b-lbpm3 as a template, and the primer IF: CTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGTCAGAAAGGCTGGAAATTTCAGGGTGAACAGGGTG, IR: ACTAATATTACGGCCCAGGGTCACAATC.
Primer phosphorylation system: NEB T4 PNK buffer 2. Mu.L, ATP (100 mM) 1. Mu.L, NEB T4 PNK 1. Mu.L, IF (100. Mu.M) 2. Mu.L, and double distilled water 14. Mu.L were added.
PCR reaction System (50. Mu.L): 1 ng/. Mu.L template, 0.2mM dATP,0.2mM dGTP,1mM dCTP,1mM dTTP,5mM MgCl2,0.4. Mu.M primer (phosphorylated IF and IR), 0.05U/LNEB Taqpolymerase.
The amplification conditions of the error-prone PCR reaction are as follows: pre-denaturation at 94℃for 4min; then, 18 cycles were performed at 94℃for 30s,56℃for 30s, and 68℃for 2min, and finally, the temperature was kept at 72℃for 5min.
The plasmid skeleton is amplified by adopting a rapid PCR technology and using pET20b as a template, and a primer VF: CTCGAGCACCACCACCACCACCACTGAGATCC, VR: CACCCTGTTCACCCTGAAATTTCCAGCCTTTCTGACCCATGGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAG.
Primer phosphorylation system: NEB T4 PNK buffer 2. Mu.L, ATP (100 mM) 1. Mu.L, NEB T4 PNK 1. Mu.L, VR (100. Mu.M) 2. Mu.L, and double distilled water 14. Mu.L were added.
The PCR reaction system is as follows: 10. Mu.L of buffer, 4. Mu.L of dNTPs (2.5 mM each), 1. Mu.L of VF (10. Mu.M), 1. Mu.L of phosphorylated VR (10. Mu.M), 1. Mu.L of template DNA, 0.5. Mu.L of NEB high-fidelity Q5 DNApolymerase (2.5U/. Mu.L), and 32.5. Mu.L of double distilled water were added.
The PCR amplification conditions are as follows: pre-denaturation at 98℃for 2min; then, 30 cycles were performed at 98℃for 10s,55℃for 15s, and 72℃for 2min, and finally, the temperature was kept at 72℃for 5min.
The PCR reaction system is as follows: 10. Mu.L of buffer, 4. Mu.L of dNTPs (2.5 mM each), 1. Mu.L of phosphorylated forward primer (10. Mu.M), 1. Mu.L of phosphorylated reverse primer (10. Mu.M), 1. Mu.L of template DNA, 0.5. Mu.L of NEB high-fidelity Q5 DNApolymerase (2.5U/. Mu.L), and 32.5. Mu.L of double distilled water were added.
The PCR amplification conditions are as follows: pre-denaturation at 98℃for 2min; then, 30 cycles were performed at 98℃for 10s,55℃for 15s, and 72℃for 2min, and finally, the temperature was kept at 72℃for 5min.
The PCR products of the fragment and plasmid backbone were digested with DpnI for 0.5h, purified by TIAN quick Midi purification kit (Tiangen, beijin, china) and subjected to overlap extension PCR (OE-PCR).
The PCR reaction system is as follows: 10. Mu.L of buffer, 4. Mu.L of dNTPs (2.5 mM each), 1. Mu.L of phosphorylated primer IF/VR (10. Mu.M), 2 ng/. Mu.L of fragment, 4 ng/. Mu.L of carrier backbone (equimolar concentration to fragment), 0.5. Mu.L of NEB high-fidelity Q5 DNApolymerase (2.5U/. Mu.L) and 50. Mu.L of double distilled water were added.
The PCR amplification conditions are as follows: pre-denaturation at 98℃for 2min; then, 30 cycles were performed at 98℃for 10s,60℃for 15s, and 72℃for 4min, and finally, the temperature was kept at 72℃for 10min.
NEB Quick Ligation kit the linear plasmids are connected into a ring, transferred into competent cells of E.coli TOP10, spread on LB solid medium containing agar for culturing overnight, heat-treated at 70 ℃ for 1h, covered with chromogenic two-layer plates, picked up positive clones, extracted plasmids, transferred into competent cells of E.coli BL21 (DE 3) for enzyme expression purification, and the thermal stability of the enzyme is measured.
Screening of the mutants was performed at 65℃to give D452G mutants (i.e.mutant M4) with the most pronounced increase in thermal stability over mutant LBP-M3, increasing the half-life of LBP pure enzyme from 2min to 15min at 65℃ (FIG. 3) and from 3.46h to 5.13h at 60℃ (FIG. 2).
The error-prone PCR technique is used, plasmid pET20b-lbpm4 with the gene of mutant LBP-M4 expressed is used as a template, library establishment and screening are continued, and the obtained mutant M5 (E11I Q12V D171N C877F D452G L Q) is used for continuously improving the half-life of LBP pure enzyme to 1.21h at 65 ℃ and improving the half-life to 7.70h at 60 ℃ from 5.13h (figure 2).
The error-prone PCR technique was used to continue library screening using plasmid pET20b-lbpm5 expressing the gene of mutant LBP-M5 as a template, and the resulting mutant M6 (E11I Q12V D171N C877F D452G L Q I186T) continued to increase the half-life of LBP-purified enzyme to 3.11h at 65℃and to 9.76h at 60℃from 7.7h (FIG. 3).
EXAMPLE 3 production of laminarin when the reaction temperature was increased to 60 ℃
The catalytic pathway for the conversion of starch to laminariae disaccharide by the in vitro multienzyme catalytic system is shown in FIG. 4. The key enzymes and key steps involved therein include: (1) Starch phosphorylase (αgp, EC 2.4.1.1) for liberating glucose-1-phosphate from starch; (2) Glucosidase (αg, EC 3.2.1.20) for liberating glucose from starch; (3) A mutant laminariae disaccharide phosphorylase (LBP, EC 2.4.1.31) M6 for catalyzing the production of laminarin from glucose-1-phosphate and glucose. The isoamylase can assist in hydrolyzing starch, i.e. adding isoamylase (IA, EC 3.2.1.68) capable of helping starch hydrolysis to the reaction system can improve laminaria disaccharide yield.
In this example, the starch phosphorylase is derived from Thermotoga maritima (Thermotoga maritima), the gene of which is numbered TM1168 on the KEGG; the glucosidase is derived from paecilomyces lilacinus (Paecilomyces lilacinus), and the gene of the glucosidase is numbered QAQ81244 on KEGG; the isoamylase is derived from sulfolobus (Sulfolobus tokodaii) and its gene is numbered ST0928 on KEGG. These genomic DNAs are available from the official website of ATCC (www.atcc.org). These three genes were obtained by PCR from the corresponding genomic DNA using F1/R1, F2/R2 and F3/R3, respectively, wherein F1: GTTTAACTTTAAGAAGGAGATATAGTGCTGGAGAAACTTCCCGAG, R1: GTGGTGGTGGTGGTGCTCGAGTCAGAGAACCTTCTTCCAGAC, F2: CATCATCATCATCATCACAGCAGCGGCTTGAAAAAAACATGGTGGAAAGAAG, R2: GTGGTGGTGGTGGTGGTGCTCGAGTTCTTTCCAGATGTATACGCGCGCC, F3: GTTTAACTTTAAGAAGGAGATATACCATGGGTCAGAAAGGCTGGAAATTTC, R3: CAGTGGTGGTGGTGGTGGTGCTCGAGACTAATATTACGGCCCAGGGTCAC and cloned into pET20b vectors (Novagen, madison, wis.) by Simple Cloning (Young C, zhang XZ, zhangY-HP.2012.simple Cloning via direct transformation ofPCR product (DNA Multi) to Escherichia coli and Bacillus subli.Appl.environmental.Microbiol.78 (5): 1593-5.) to obtain the corresponding expression vectors pET20b-Tm αGP, pET20b-PlαG and pET20b-StIA. The laminaria disaccharide phosphorylase was derived from Pseudomonas (Paenibacillus sp.YM1) using the mutant M6 of example 2, SEQ ID NO.7 and pET20b-lbpm6 as expression vector. Then, these four plasmids were transformed into E.coli expression bacterium BL21 (DE 3) (Invitrogen, carlsbad, calif.), respectively, and protein expression and purification were performed, and the results of protein purification are shown in FIG. 2.
The reaction system contained 5mM sodium acetate buffer (pH 5.5), 0.5mM divalent zinc ion, 5U/mL isoamylase, 200g/L starch, and the reaction time was 3 hours at 85 ℃.
The reaction system then contained 100mM HEPES buffer (pH 6.5), 5mM divalent zinc ion, 20mM potassium phosphate (pH 6.5), 3U/mL starch phosphorylase, 1U/mL glucosidase, 2U/mL laminaria disaccharide phosphorylase, 10g/LIA treated starch, and the reaction was catalyzed at 60℃for 8 hours.
High performance liquid chromatography is used for detecting laminarin concentration. 94.5. Mu.L of the reaction sample was taken and the reaction was stopped by adding 5.5. Mu.L of 10% sulfuric acid. Centrifuging to obtain supernatant, and detecting peak area and peak height of laminariae disaccharide by HPLC to calculate laminarin concentration.
After completion of the reaction, the final concentration of laminariae disaccharide produced by LBP mutant M6 (FIG. 5) was 22.4mM, the conversion rate relative to starch (10 g/L, about 55.5mM glucose equivalent, 2 molecules glucose equivalent to 1 molecule laminariae disaccharide) was 80.7%, and the final concentration of laminaria disaccharide produced by LBP wild-type catalysis was only 5.4mM, the conversion rate relative to starch was 19.4%.
The embodiments of the present invention have been described above. However, the present invention is not limited to the above embodiment. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Sequence listing
<110> institute of Tianjin Industrial biotechnology, national academy of sciences
<120> a laminarin phosphorylase mutant with improved thermostability and use thereof
<160> 7
<170> SIPOSequenceListing 1.0
<210> 1
<211> 911
<212> PRT
<213> Paenibacillus sp.YM1
<400> 1
Met Gly Gln Lys Gly Trp Lys Phe Gln Gly Glu Gln Gly Glu Phe Arg
1 5 10 15
Leu Glu Gln Pro Glu His Asn Ser Tyr Leu Tyr Phe Pro Leu Val Asn
20 25 30
Glu Ala Gly Met Met Ser Ala Val Thr Pro Asn Leu His Gly Glu Ile
35 40 45
Thr Ser Gly His Asn Thr Phe Leu Met Glu Pro Val Ser Ala Glu Ser
50 55 60
Leu His Asn Ser Lys Ala Ser Arg Asn Phe Trp Val Phe Ile Glu Gly
65 70 75 80
Tyr Gly Ala Trp Ser Val Ser Gly Asn Ser Ala Arg Gln Asn Ala Ala
85 90 95
Arg Phe Thr Gly Glu Glu Glu Arg Ser Ala Val Glu Ala Gly Phe Leu
100 105 110
Trp His Ala Val Thr Arg Glu Asn Glu Lys Ala Gly Leu Lys Ala Arg
115 120 125
Thr Val Ser Phe Val Pro Val Thr Asp Asp Lys Ile Glu Leu Met Arg
130 135 140
Val Thr Leu Thr Asn Thr Gly Asn Ala Pro Leu Lys Leu Thr Pro Thr
145 150 155 160
Ala Ala Ile Pro Leu Tyr Gly Arg Ser Ala Asp Asp Leu Arg Asp His
165 170 175
Arg His Val Thr Ser Leu Leu His Arg Ile Phe Thr Ser Glu Tyr Gly
180 185 190
Ile Glu Val Gln Pro Ala Leu Ser Phe Asp Glu Arg Gly His Arg Val
195 200 205
Asn Lys Val Thr Tyr Gly Val Phe Gly Ala Glu Ala Gly Gly Thr Ala
210 215 220
Pro Ala Gly Phe Phe Pro Val Thr Glu Asp Phe Ile Gly Glu Gly Gly
225 230 235 240
Ala Leu Asp Trp Pro Glu Ala Val Val Ala Asn Arg Glu Pro Asp Ala
245 250 255
Gln Ala Gly Thr Ala Val Glu Gly Tyr Glu Ala Val Gly Ala Leu Arg
260 265 270
Phe Ala Pro Val Glu Leu Ala Pro Gly Lys Ser Val Ser Tyr Val Val
275 280 285
Ala Met Val Ile Ser Gly Asp Arg Ile Asp Val Gly Arg Tyr Ala Ala
290 295 300
Asp Tyr Leu Ala Ala Gly Arg Phe Asp Ala Leu Leu Glu Gln Asn Arg
305 310 315 320
Ala Tyr Trp Arg Asp Lys Leu Asp Thr Val Arg Phe Ser Ser Gly Asp
325 330 335
Gly Glu Gln Asp Leu Trp Met Lys Trp Val Thr Leu Gln Pro Ile Leu
340 345 350
Arg Arg Leu Tyr Gly Asn Ser Phe Leu Pro Tyr His Asp Tyr Gly Arg
355 360 365
Gly Gly Arg Gly Trp Arg Asp Leu Trp Gln Asp Cys Leu Ala Leu Met
370 375 380
Val Met Glu Pro Ala Glu Val Arg His Leu Leu Leu Asn Asn Tyr Ala
385 390 395 400
Gly Val Arg Met Asp Gly Ser Asn Ala Thr Ile Ile Gly Ala Gly Pro
405 410 415
Gly Glu Phe Val Ala Asp Arg Asn Asn Ile Pro Arg Val Trp Met Asp
420 425 430
His Gly Ala Trp Pro Leu Met Thr Thr Leu Leu Tyr Leu His Gln Ser
435 440 445
Gly Asp Leu Asp Leu Leu Phe Gln Pro Gln Ser Tyr Phe Arg Asp Val
450 455 460
Phe Val Lys Arg Cys Arg Glu Arg Asp Ala Ser Trp Thr Pro Glu Gln
465 470 475 480
Gly Asn Lys Leu Leu Thr Ala Asp Gly Gln Ile Tyr Glu Gly Thr Ile
485 490 495
Leu Glu His Ile Leu Leu Gln Asn Ile Val Pro Phe Phe Asn Val Gly
500 505 510
Glu His Gly Asn Ile Lys Leu Glu Gly Ala Asp Trp Asn Asp Gly Leu
515 520 525
Asp Leu Ala Pro Glu Arg Gly Glu Ser Val Ala Phe Thr Ala Phe Tyr
530 535 540
Ala Ser Asn Leu Met Glu Leu Ser Glu Leu Leu Leu Glu Leu Gln Lys
545 550 555 560
Arg Thr Gly Lys Asp Ser Leu Asp Ile Ala Glu Glu Met Ala Leu Leu
565 570 575
Leu Asp Thr Leu Gly Lys Pro Ile Ser Tyr Asp Ser Ile Gln Glu Lys
580 585 590
Arg Ser Leu Leu Asp Arg Tyr Tyr Asp Ala Val Thr Pro Arg Val Ser
595 600 605
Gly Lys Lys Leu Leu Leu Asp Ile Arg Lys Val Ala Glu Asp Leu Lys
610 615 620
Arg Lys Ala Asp Trp Ala Val Ala His Leu Arg Gly Ser Glu Trp Ile
625 630 635 640
Gln Ser Lys Glu Gly Tyr Ala Trp Phe Asn Gly Tyr Tyr Asn Asn Asp
645 650 655
Gly Glu Arg Val Glu Gly Asp His Pro Asp Gly Val Arg Met Thr Leu
660 665 670
Thr Gly Gln Val Phe Ala Ile Met Gly Gly Val Ala Thr Asp Glu Gln
675 680 685
Thr Glu Lys Ile Ser Gln Ala Val Asn Arg Tyr Leu Lys Asp Glu Arg
690 695 700
Ile Gly Tyr Arg Leu Asn Ser Arg Phe Gly Gly Ile Gln Gln Asn Leu
705 710 715 720
Gly Arg Ala Phe Gly Phe Ala Phe Gly His Lys Glu Asn Gly Ala Met
725 730 735
Phe Ser His Met Thr Val Met Tyr Ala Asn Ala Leu Tyr Lys Arg Gly
740 745 750
Phe Val Gln Glu Gly Phe Glu Val Leu Asp Ser Ile Tyr Arg Leu Ser
755 760 765
Ala Asp Phe Glu Asn Ser Arg Ile Tyr Pro Gly Val Pro Glu Tyr Ile
770 775 780
Asn Glu Arg Gly Arg Gly Met Tyr Thr Tyr Leu Thr Gly Ser Ala Ser
785 790 795 800
Trp Leu Leu Leu Thr Gln Leu Thr Glu Val Tyr Gly Val Lys Gly Arg
805 810 815
Phe Gly Asp Leu Arg Leu Glu Pro Lys Leu Val Gln Ala Gln Phe Asp
820 825 830
Gly Ser Gly Glu Ala Ala Val Glu Thr Leu Phe Ala Gly Arg Met Leu
835 840 845
Arg Val Val Tyr Arg Asn Pro Gln Ala Ala Glu His Gly Gln Tyr Arg
850 855 860
Val Asp Ser Val Ser Leu Asn Gly Gln Ser Val Asp Cys Gln Asn Asp
865 870 875 880
Gly Ala Gly Cys Leu Ile Gly Arg Ser Leu Ile Glu Ala Leu Pro Ala
885 890 895
Asp Gly Val His Glu Leu Ile Val Thr Leu Gly Arg Asn Ile Ser
900 905 910
<210> 2
<211> 911
<212> PRT
<213> Artificial sequence ()
<400> 2
Met Gly Gln Lys Gly Trp Lys Phe Gln Gly Ile Val Gly Glu Phe Arg
1 5 10 15
Leu Glu Gln Pro Glu His Asn Ser Tyr Leu Tyr Phe Pro Leu Val Asn
20 25 30
Glu Ala Gly Met Met Ser Ala Val Thr Pro Asn Leu His Gly Glu Ile
35 40 45
Thr Ser Gly His Asn Thr Phe Leu Met Glu Pro Val Ser Ala Glu Ser
50 55 60
Leu His Asn Ser Lys Ala Ser Arg Asn Phe Trp Val Phe Ile Glu Gly
65 70 75 80
Tyr Gly Ala Trp Ser Val Ser Gly Asn Ser Ala Arg Gln Asn Ala Ala
85 90 95
Arg Phe Thr Gly Glu Glu Glu Arg Ser Ala Val Glu Ala Gly Phe Leu
100 105 110
Trp His Ala Val Thr Arg Glu Asn Glu Lys Ala Gly Leu Lys Ala Arg
115 120 125
Thr Val Ser Phe Val Pro Val Thr Asp Asp Lys Ile Glu Leu Met Arg
130 135 140
Val Thr Leu Thr Asn Thr Gly Asn Ala Pro Leu Lys Leu Thr Pro Thr
145 150 155 160
Ala Ala Ile Pro Leu Tyr Gly Arg Ser Ala Asp Asp Leu Arg Asp His
165 170 175
Arg His Val Thr Ser Leu Leu His Arg Ile Phe Thr Ser Glu Tyr Gly
180 185 190
Ile Glu Val Gln Pro Ala Leu Ser Phe Asp Glu Arg Gly His Arg Val
195 200 205
Asn Lys Val Thr Tyr Gly Val Phe Gly Ala Glu Ala Gly Gly Thr Ala
210 215 220
Pro Ala Gly Phe Phe Pro Val Thr Glu Asp Phe Ile Gly Glu Gly Gly
225 230 235 240
Ala Leu Asp Trp Pro Glu Ala Val Val Ala Asn Arg Glu Pro Asp Ala
245 250 255
Gln Ala Gly Thr Ala Val Glu Gly Tyr Glu Ala Val Gly Ala Leu Arg
260 265 270
Phe Ala Pro Val Glu Leu Ala Pro Gly Lys Ser Val Ser Tyr Val Val
275 280 285
Ala Met Val Ile Ser Gly Asp Arg Ile Asp Val Gly Arg Tyr Ala Ala
290 295 300
Asp Tyr Leu Ala Ala Gly Arg Phe Asp Ala Leu Leu Glu Gln Asn Arg
305 310 315 320
Ala Tyr Trp Arg Asp Lys Leu Asp Thr Val Arg Phe Ser Ser Gly Asp
325 330 335
Gly Glu Gln Asp Leu Trp Met Lys Trp Val Thr Leu Gln Pro Ile Leu
340 345 350
Arg Arg Leu Tyr Gly Asn Ser Phe Leu Pro Tyr His Asp Tyr Gly Arg
355 360 365
Gly Gly Arg Gly Trp Arg Asp Leu Trp Gln Asp Cys Leu Ala Leu Met
370 375 380
Val Met Glu Pro Ala Glu Val Arg His Leu Leu Leu Asn Asn Tyr Ala
385 390 395 400
Gly Val Arg Met Asp Gly Ser Asn Ala Thr Ile Ile Gly Ala Gly Pro
405 410 415
Gly Glu Phe Val Ala Asp Arg Asn Asn Ile Pro Arg Val Trp Met Asp
420 425 430
His Gly Ala Trp Pro Leu Met Thr Thr Leu Leu Tyr Leu His Gln Ser
435 440 445
Gly Asp Leu Asp Leu Leu Phe Gln Pro Gln Ser Tyr Phe Arg Asp Val
450 455 460
Phe Val Lys Arg Cys Arg Glu Arg Asp Ala Ser Trp Thr Pro Glu Gln
465 470 475 480
Gly Asn Lys Leu Leu Thr Ala Asp Gly Gln Ile Tyr Glu Gly Thr Ile
485 490 495
Leu Glu His Ile Leu Leu Gln Asn Ile Val Pro Phe Phe Asn Val Gly
500 505 510
Glu His Gly Asn Ile Lys Leu Glu Gly Ala Asp Trp Asn Asp Gly Leu
515 520 525
Asp Leu Ala Pro Glu Arg Gly Glu Ser Val Ala Phe Thr Ala Phe Tyr
530 535 540
Ala Ser Asn Leu Met Glu Leu Ser Glu Leu Leu Leu Glu Leu Gln Lys
545 550 555 560
Arg Thr Gly Lys Asp Ser Leu Asp Ile Ala Glu Glu Met Ala Leu Leu
565 570 575
Leu Asp Thr Leu Gly Lys Pro Ile Ser Tyr Asp Ser Ile Gln Glu Lys
580 585 590
Arg Ser Leu Leu Asp Arg Tyr Tyr Asp Ala Val Thr Pro Arg Val Ser
595 600 605
Gly Lys Lys Leu Leu Leu Asp Ile Arg Lys Val Ala Glu Asp Leu Lys
610 615 620
Arg Lys Ala Asp Trp Ala Val Ala His Leu Arg Gly Ser Glu Trp Ile
625 630 635 640
Gln Ser Lys Glu Gly Tyr Ala Trp Phe Asn Gly Tyr Tyr Asn Asn Asp
645 650 655
Gly Glu Arg Val Glu Gly Asp His Pro Asp Gly Val Arg Met Thr Leu
660 665 670
Thr Gly Gln Val Phe Ala Ile Met Gly Gly Val Ala Thr Asp Glu Gln
675 680 685
Thr Glu Lys Ile Ser Gln Ala Val Asn Arg Tyr Leu Lys Asp Glu Arg
690 695 700
Ile Gly Tyr Arg Leu Asn Ser Arg Phe Gly Gly Ile Gln Gln Asn Leu
705 710 715 720
Gly Arg Ala Phe Gly Phe Ala Phe Gly His Lys Glu Asn Gly Ala Met
725 730 735
Phe Ser His Met Thr Val Met Tyr Ala Asn Ala Leu Tyr Lys Arg Gly
740 745 750
Phe Val Gln Glu Gly Phe Glu Val Leu Asp Ser Ile Tyr Arg Leu Ser
755 760 765
Ala Asp Phe Glu Asn Ser Arg Ile Tyr Pro Gly Val Pro Glu Tyr Ile
770 775 780
Asn Glu Arg Gly Arg Gly Met Tyr Thr Tyr Leu Thr Gly Ser Ala Ser
785 790 795 800
Trp Leu Leu Leu Thr Gln Leu Thr Glu Val Tyr Gly Val Lys Gly Arg
805 810 815
Phe Gly Asp Leu Arg Leu Glu Pro Lys Leu Val Gln Ala Gln Phe Asp
820 825 830
Gly Ser Gly Glu Ala Ala Val Glu Thr Leu Phe Ala Gly Arg Met Leu
835 840 845
Arg Val Val Tyr Arg Asn Pro Gln Ala Ala Glu His Gly Gln Tyr Arg
850 855 860
Val Asp Ser Val Ser Leu Asn Gly Gln Ser Val Asp Cys Gln Asn Asp
865 870 875 880
Gly Ala Gly Cys Leu Ile Gly Arg Ser Leu Ile Glu Ala Leu Pro Ala
885 890 895
Asp Gly Val His Glu Leu Ile Val Thr Leu Gly Arg Asn Ile Ser
900 905 910
<210> 3
<211> 911
<212> PRT
<213> Artificial sequence ()
<400> 3
Met Gly Gln Lys Gly Trp Lys Phe Gln Gly Ile Val Gly Glu Phe Arg
1 5 10 15
Leu Glu Gln Pro Glu His Asn Ser Tyr Leu Tyr Phe Pro Leu Val Asn
20 25 30
Glu Ala Gly Met Met Ser Ala Val Thr Pro Asn Leu His Gly Glu Ile
35 40 45
Thr Ser Gly His Asn Thr Phe Leu Met Glu Pro Val Ser Ala Glu Ser
50 55 60
Leu His Asn Ser Lys Ala Ser Arg Asn Phe Trp Val Phe Ile Glu Gly
65 70 75 80
Tyr Gly Ala Trp Ser Val Ser Gly Asn Ser Ala Arg Gln Asn Ala Ala
85 90 95
Arg Phe Thr Gly Glu Glu Glu Arg Ser Ala Val Glu Ala Gly Phe Leu
100 105 110
Trp His Ala Val Thr Arg Glu Asn Glu Lys Ala Gly Leu Lys Ala Arg
115 120 125
Thr Val Ser Phe Val Pro Val Thr Asp Asp Lys Ile Glu Leu Met Arg
130 135 140
Val Thr Leu Thr Asn Thr Gly Asn Ala Pro Leu Lys Leu Thr Pro Thr
145 150 155 160
Ala Ala Ile Pro Leu Tyr Gly Arg Ser Ala Asn Asp Leu Arg Asp His
165 170 175
Arg His Val Thr Ser Leu Leu His Arg Ile Phe Thr Ser Glu Tyr Gly
180 185 190
Ile Glu Val Gln Pro Ala Leu Ser Phe Asp Glu Arg Gly His Arg Val
195 200 205
Asn Lys Val Thr Tyr Gly Val Phe Gly Ala Glu Ala Gly Gly Thr Ala
210 215 220
Pro Ala Gly Phe Phe Pro Val Thr Glu Asp Phe Ile Gly Glu Gly Gly
225 230 235 240
Ala Leu Asp Trp Pro Glu Ala Val Val Ala Asn Arg Glu Pro Asp Ala
245 250 255
Gln Ala Gly Thr Ala Val Glu Gly Tyr Glu Ala Val Gly Ala Leu Arg
260 265 270
Phe Ala Pro Val Glu Leu Ala Pro Gly Lys Ser Val Ser Tyr Val Val
275 280 285
Ala Met Val Ile Ser Gly Asp Arg Ile Asp Val Gly Arg Tyr Ala Ala
290 295 300
Asp Tyr Leu Ala Ala Gly Arg Phe Asp Ala Leu Leu Glu Gln Asn Arg
305 310 315 320
Ala Tyr Trp Arg Asp Lys Leu Asp Thr Val Arg Phe Ser Ser Gly Asp
325 330 335
Gly Glu Gln Asp Leu Trp Met Lys Trp Val Thr Leu Gln Pro Ile Leu
340 345 350
Arg Arg Leu Tyr Gly Asn Ser Phe Leu Pro Tyr His Asp Tyr Gly Arg
355 360 365
Gly Gly Arg Gly Trp Arg Asp Leu Trp Gln Asp Cys Leu Ala Leu Met
370 375 380
Val Met Glu Pro Ala Glu Val Arg His Leu Leu Leu Asn Asn Tyr Ala
385 390 395 400
Gly Val Arg Met Asp Gly Ser Asn Ala Thr Ile Ile Gly Ala Gly Pro
405 410 415
Gly Glu Phe Val Ala Asp Arg Asn Asn Ile Pro Arg Val Trp Met Asp
420 425 430
His Gly Ala Trp Pro Leu Met Thr Thr Leu Leu Tyr Leu His Gln Ser
435 440 445
Gly Asp Leu Asp Leu Leu Phe Gln Pro Gln Ser Tyr Phe Arg Asp Val
450 455 460
Phe Val Lys Arg Cys Arg Glu Arg Asp Ala Ser Trp Thr Pro Glu Gln
465 470 475 480
Gly Asn Lys Leu Leu Thr Ala Asp Gly Gln Ile Tyr Glu Gly Thr Ile
485 490 495
Leu Glu His Ile Leu Leu Gln Asn Ile Val Pro Phe Phe Asn Val Gly
500 505 510
Glu His Gly Asn Ile Lys Leu Glu Gly Ala Asp Trp Asn Asp Gly Leu
515 520 525
Asp Leu Ala Pro Glu Arg Gly Glu Ser Val Ala Phe Thr Ala Phe Tyr
530 535 540
Ala Ser Asn Leu Met Glu Leu Ser Glu Leu Leu Leu Glu Leu Gln Lys
545 550 555 560
Arg Thr Gly Lys Asp Ser Leu Asp Ile Ala Glu Glu Met Ala Leu Leu
565 570 575
Leu Asp Thr Leu Gly Lys Pro Ile Ser Tyr Asp Ser Ile Gln Glu Lys
580 585 590
Arg Ser Leu Leu Asp Arg Tyr Tyr Asp Ala Val Thr Pro Arg Val Ser
595 600 605
Gly Lys Lys Leu Leu Leu Asp Ile Arg Lys Val Ala Glu Asp Leu Lys
610 615 620
Arg Lys Ala Asp Trp Ala Val Ala His Leu Arg Gly Ser Glu Trp Ile
625 630 635 640
Gln Ser Lys Glu Gly Tyr Ala Trp Phe Asn Gly Tyr Tyr Asn Asn Asp
645 650 655
Gly Glu Arg Val Glu Gly Asp His Pro Asp Gly Val Arg Met Thr Leu
660 665 670
Thr Gly Gln Val Phe Ala Ile Met Gly Gly Val Ala Thr Asp Glu Gln
675 680 685
Thr Glu Lys Ile Ser Gln Ala Val Asn Arg Tyr Leu Lys Asp Glu Arg
690 695 700
Ile Gly Tyr Arg Leu Asn Ser Arg Phe Gly Gly Ile Gln Gln Asn Leu
705 710 715 720
Gly Arg Ala Phe Gly Phe Ala Phe Gly His Lys Glu Asn Gly Ala Met
725 730 735
Phe Ser His Met Thr Val Met Tyr Ala Asn Ala Leu Tyr Lys Arg Gly
740 745 750
Phe Val Gln Glu Gly Phe Glu Val Leu Asp Ser Ile Tyr Arg Leu Ser
755 760 765
Ala Asp Phe Glu Asn Ser Arg Ile Tyr Pro Gly Val Pro Glu Tyr Ile
770 775 780
Asn Glu Arg Gly Arg Gly Met Tyr Thr Tyr Leu Thr Gly Ser Ala Ser
785 790 795 800
Trp Leu Leu Leu Thr Gln Leu Thr Glu Val Tyr Gly Val Lys Gly Arg
805 810 815
Phe Gly Asp Leu Arg Leu Glu Pro Lys Leu Val Gln Ala Gln Phe Asp
820 825 830
Gly Ser Gly Glu Ala Ala Val Glu Thr Leu Phe Ala Gly Arg Met Leu
835 840 845
Arg Val Val Tyr Arg Asn Pro Gln Ala Ala Glu His Gly Gln Tyr Arg
850 855 860
Val Asp Ser Val Ser Leu Asn Gly Gln Ser Val Asp Cys Gln Asn Asp
865 870 875 880
Gly Ala Gly Cys Leu Ile Gly Arg Ser Leu Ile Glu Ala Leu Pro Ala
885 890 895
Asp Gly Val His Glu Leu Ile Val Thr Leu Gly Arg Asn Ile Ser
900 905 910
<210> 4
<211> 911
<212> PRT
<213> Artificial sequence ()
<400> 4
Met Gly Gln Lys Gly Trp Lys Phe Gln Gly Ile Val Gly Glu Phe Arg
1 5 10 15
Leu Glu Gln Pro Glu His Asn Ser Tyr Leu Tyr Phe Pro Leu Val Asn
20 25 30
Glu Ala Gly Met Met Ser Ala Val Thr Pro Asn Leu His Gly Glu Ile
35 40 45
Thr Ser Gly His Asn Thr Phe Leu Met Glu Pro Val Ser Ala Glu Ser
50 55 60
Leu His Asn Ser Lys Ala Ser Arg Asn Phe Trp Val Phe Ile Glu Gly
65 70 75 80
Tyr Gly Ala Trp Ser Val Ser Gly Asn Ser Ala Arg Gln Asn Ala Ala
85 90 95
Arg Phe Thr Gly Glu Glu Glu Arg Ser Ala Val Glu Ala Gly Phe Leu
100 105 110
Trp His Ala Val Thr Arg Glu Asn Glu Lys Ala Gly Leu Lys Ala Arg
115 120 125
Thr Val Ser Phe Val Pro Val Thr Asp Asp Lys Ile Glu Leu Met Arg
130 135 140
Val Thr Leu Thr Asn Thr Gly Asn Ala Pro Leu Lys Leu Thr Pro Thr
145 150 155 160
Ala Ala Ile Pro Leu Tyr Gly Arg Ser Ala Asn Asp Leu Arg Asp His
165 170 175
Arg His Val Thr Ser Leu Leu His Arg Ile Phe Thr Ser Glu Tyr Gly
180 185 190
Ile Glu Val Gln Pro Ala Leu Ser Phe Asp Glu Arg Gly His Arg Val
195 200 205
Asn Lys Val Thr Tyr Gly Val Phe Gly Ala Glu Ala Gly Gly Thr Ala
210 215 220
Pro Ala Gly Phe Phe Pro Val Thr Glu Asp Phe Ile Gly Glu Gly Gly
225 230 235 240
Ala Leu Asp Trp Pro Glu Ala Val Val Ala Asn Arg Glu Pro Asp Ala
245 250 255
Gln Ala Gly Thr Ala Val Glu Gly Tyr Glu Ala Val Gly Ala Leu Arg
260 265 270
Phe Ala Pro Val Glu Leu Ala Pro Gly Lys Ser Val Ser Tyr Val Val
275 280 285
Ala Met Val Ile Ser Gly Asp Arg Ile Asp Val Gly Arg Tyr Ala Ala
290 295 300
Asp Tyr Leu Ala Ala Gly Arg Phe Asp Ala Leu Leu Glu Gln Asn Arg
305 310 315 320
Ala Tyr Trp Arg Asp Lys Leu Asp Thr Val Arg Phe Ser Ser Gly Asp
325 330 335
Gly Glu Gln Asp Leu Trp Met Lys Trp Val Thr Leu Gln Pro Ile Leu
340 345 350
Arg Arg Leu Tyr Gly Asn Ser Phe Leu Pro Tyr His Asp Tyr Gly Arg
355 360 365
Gly Gly Arg Gly Trp Arg Asp Leu Trp Gln Asp Cys Leu Ala Leu Met
370 375 380
Val Met Glu Pro Ala Glu Val Arg His Leu Leu Leu Asn Asn Tyr Ala
385 390 395 400
Gly Val Arg Met Asp Gly Ser Asn Ala Thr Ile Ile Gly Ala Gly Pro
405 410 415
Gly Glu Phe Val Ala Asp Arg Asn Asn Ile Pro Arg Val Trp Met Asp
420 425 430
His Gly Ala Trp Pro Leu Met Thr Thr Leu Leu Tyr Leu His Gln Ser
435 440 445
Gly Asp Leu Asp Leu Leu Phe Gln Pro Gln Ser Tyr Phe Arg Asp Val
450 455 460
Phe Val Lys Arg Cys Arg Glu Arg Asp Ala Ser Trp Thr Pro Glu Gln
465 470 475 480
Gly Asn Lys Leu Leu Thr Ala Asp Gly Gln Ile Tyr Glu Gly Thr Ile
485 490 495
Leu Glu His Ile Leu Leu Gln Asn Ile Val Pro Phe Phe Asn Val Gly
500 505 510
Glu His Gly Asn Ile Lys Leu Glu Gly Ala Asp Trp Asn Asp Gly Leu
515 520 525
Asp Leu Ala Pro Glu Arg Gly Glu Ser Val Ala Phe Thr Ala Phe Tyr
530 535 540
Ala Ser Asn Leu Met Glu Leu Ser Glu Leu Leu Leu Glu Leu Gln Lys
545 550 555 560
Arg Thr Gly Lys Asp Ser Leu Asp Ile Ala Glu Glu Met Ala Leu Leu
565 570 575
Leu Asp Thr Leu Gly Lys Pro Ile Ser Tyr Asp Ser Ile Gln Glu Lys
580 585 590
Arg Ser Leu Leu Asp Arg Tyr Tyr Asp Ala Val Thr Pro Arg Val Ser
595 600 605
Gly Lys Lys Leu Leu Leu Asp Ile Arg Lys Val Ala Glu Asp Leu Lys
610 615 620
Arg Lys Ala Asp Trp Ala Val Ala His Leu Arg Gly Ser Glu Trp Ile
625 630 635 640
Gln Ser Lys Glu Gly Tyr Ala Trp Phe Asn Gly Tyr Tyr Asn Asn Asp
645 650 655
Gly Glu Arg Val Glu Gly Asp His Pro Asp Gly Val Arg Met Thr Leu
660 665 670
Thr Gly Gln Val Phe Ala Ile Met Gly Gly Val Ala Thr Asp Glu Gln
675 680 685
Thr Glu Lys Ile Ser Gln Ala Val Asn Arg Tyr Leu Lys Asp Glu Arg
690 695 700
Ile Gly Tyr Arg Leu Asn Ser Arg Phe Gly Gly Ile Gln Gln Asn Leu
705 710 715 720
Gly Arg Ala Phe Gly Phe Ala Phe Gly His Lys Glu Asn Gly Ala Met
725 730 735
Phe Ser His Met Thr Val Met Tyr Ala Asn Ala Leu Tyr Lys Arg Gly
740 745 750
Phe Val Gln Glu Gly Phe Glu Val Leu Asp Ser Ile Tyr Arg Leu Ser
755 760 765
Ala Asp Phe Glu Asn Ser Arg Ile Tyr Pro Gly Val Pro Glu Tyr Ile
770 775 780
Asn Glu Arg Gly Arg Gly Met Tyr Thr Tyr Leu Thr Gly Ser Ala Ser
785 790 795 800
Trp Leu Leu Leu Thr Gln Leu Thr Glu Val Tyr Gly Val Lys Gly Arg
805 810 815
Phe Gly Asp Leu Arg Leu Glu Pro Lys Leu Val Gln Ala Gln Phe Asp
820 825 830
Gly Ser Gly Glu Ala Ala Val Glu Thr Leu Phe Ala Gly Arg Met Leu
835 840 845
Arg Val Val Tyr Arg Asn Pro Gln Ala Ala Glu His Gly Gln Tyr Arg
850 855 860
Val Asp Ser Val Ser Leu Asn Gly Gln Ser Val Asp Phe Gln Asn Asp
865 870 875 880
Gly Ala Gly Cys Leu Ile Gly Arg Ser Leu Ile Glu Ala Leu Pro Ala
885 890 895
Asp Gly Val His Glu Leu Ile Val Thr Leu Gly Arg Asn Ile Ser
900 905 910
<210> 5
<211> 911
<212> PRT
<213> Artificial sequence ()
<400> 5
Met Gly Gln Lys Gly Trp Lys Phe Gln Gly Ile Val Gly Glu Phe Arg
1 5 10 15
Leu Glu Gln Pro Glu His Asn Ser Tyr Leu Tyr Phe Pro Leu Val Asn
20 25 30
Glu Ala Gly Met Met Ser Ala Val Thr Pro Asn Leu His Gly Glu Ile
35 40 45
Thr Ser Gly His Asn Thr Phe Leu Met Glu Pro Val Ser Ala Glu Ser
50 55 60
Leu His Asn Ser Lys Ala Ser Arg Asn Phe Trp Val Phe Ile Glu Gly
65 70 75 80
Tyr Gly Ala Trp Ser Val Ser Gly Asn Ser Ala Arg Gln Asn Ala Ala
85 90 95
Arg Phe Thr Gly Glu Glu Glu Arg Ser Ala Val Glu Ala Gly Phe Leu
100 105 110
Trp His Ala Val Thr Arg Glu Asn Glu Lys Ala Gly Leu Lys Ala Arg
115 120 125
Thr Val Ser Phe Val Pro Val Thr Asp Asp Lys Ile Glu Leu Met Arg
130 135 140
Val Thr Leu Thr Asn Thr Gly Asn Ala Pro Leu Lys Leu Thr Pro Thr
145 150 155 160
Ala Ala Ile Pro Leu Tyr Gly Arg Ser Ala Asn Asp Leu Arg Asp His
165 170 175
Arg His Val Thr Ser Leu Leu His Arg Ile Phe Thr Ser Glu Tyr Gly
180 185 190
Ile Glu Val Gln Pro Ala Leu Ser Phe Asp Glu Arg Gly His Arg Val
195 200 205
Asn Lys Val Thr Tyr Gly Val Phe Gly Ala Glu Ala Gly Gly Thr Ala
210 215 220
Pro Ala Gly Phe Phe Pro Val Thr Glu Asp Phe Ile Gly Glu Gly Gly
225 230 235 240
Ala Leu Asp Trp Pro Glu Ala Val Val Ala Asn Arg Glu Pro Asp Ala
245 250 255
Gln Ala Gly Thr Ala Val Glu Gly Tyr Glu Ala Val Gly Ala Leu Arg
260 265 270
Phe Ala Pro Val Glu Leu Ala Pro Gly Lys Ser Val Ser Tyr Val Val
275 280 285
Ala Met Val Ile Ser Gly Asp Arg Ile Asp Val Gly Arg Tyr Ala Ala
290 295 300
Asp Tyr Leu Ala Ala Gly Arg Phe Asp Ala Leu Leu Glu Gln Asn Arg
305 310 315 320
Ala Tyr Trp Arg Asp Lys Leu Asp Thr Val Arg Phe Ser Ser Gly Asp
325 330 335
Gly Glu Gln Asp Leu Trp Met Lys Trp Val Thr Leu Gln Pro Ile Leu
340 345 350
Arg Arg Leu Tyr Gly Asn Ser Phe Leu Pro Tyr His Asp Tyr Gly Arg
355 360 365
Gly Gly Arg Gly Trp Arg Asp Leu Trp Gln Asp Cys Leu Ala Leu Met
370 375 380
Val Met Glu Pro Ala Glu Val Arg His Leu Leu Leu Asn Asn Tyr Ala
385 390 395 400
Gly Val Arg Met Asp Gly Ser Asn Ala Thr Ile Ile Gly Ala Gly Pro
405 410 415
Gly Glu Phe Val Ala Asp Arg Asn Asn Ile Pro Arg Val Trp Met Asp
420 425 430
His Gly Ala Trp Pro Leu Met Thr Thr Leu Leu Tyr Leu His Gln Ser
435 440 445
Gly Asp Leu Gly Leu Leu Phe Gln Pro Gln Ser Tyr Phe Arg Asp Val
450 455 460
Phe Val Lys Arg Cys Arg Glu Arg Asp Ala Ser Trp Thr Pro Glu Gln
465 470 475 480
Gly Asn Lys Leu Leu Thr Ala Asp Gly Gln Ile Tyr Glu Gly Thr Ile
485 490 495
Leu Glu His Ile Leu Leu Gln Asn Ile Val Pro Phe Phe Asn Val Gly
500 505 510
Glu His Gly Asn Ile Lys Leu Glu Gly Ala Asp Trp Asn Asp Gly Leu
515 520 525
Asp Leu Ala Pro Glu Arg Gly Glu Ser Val Ala Phe Thr Ala Phe Tyr
530 535 540
Ala Ser Asn Leu Met Glu Leu Ser Glu Leu Leu Leu Glu Leu Gln Lys
545 550 555 560
Arg Thr Gly Lys Asp Ser Leu Asp Ile Ala Glu Glu Met Ala Leu Leu
565 570 575
Leu Asp Thr Leu Gly Lys Pro Ile Ser Tyr Asp Ser Ile Gln Glu Lys
580 585 590
Arg Ser Leu Leu Asp Arg Tyr Tyr Asp Ala Val Thr Pro Arg Val Ser
595 600 605
Gly Lys Lys Leu Leu Leu Asp Ile Arg Lys Val Ala Glu Asp Leu Lys
610 615 620
Arg Lys Ala Asp Trp Ala Val Ala His Leu Arg Gly Ser Glu Trp Ile
625 630 635 640
Gln Ser Lys Glu Gly Tyr Ala Trp Phe Asn Gly Tyr Tyr Asn Asn Asp
645 650 655
Gly Glu Arg Val Glu Gly Asp His Pro Asp Gly Val Arg Met Thr Leu
660 665 670
Thr Gly Gln Val Phe Ala Ile Met Gly Gly Val Ala Thr Asp Glu Gln
675 680 685
Thr Glu Lys Ile Ser Gln Ala Val Asn Arg Tyr Leu Lys Asp Glu Arg
690 695 700
Ile Gly Tyr Arg Leu Asn Ser Arg Phe Gly Gly Ile Gln Gln Asn Leu
705 710 715 720
Gly Arg Ala Phe Gly Phe Ala Phe Gly His Lys Glu Asn Gly Ala Met
725 730 735
Phe Ser His Met Thr Val Met Tyr Ala Asn Ala Leu Tyr Lys Arg Gly
740 745 750
Phe Val Gln Glu Gly Phe Glu Val Leu Asp Ser Ile Tyr Arg Leu Ser
755 760 765
Ala Asp Phe Glu Asn Ser Arg Ile Tyr Pro Gly Val Pro Glu Tyr Ile
770 775 780
Asn Glu Arg Gly Arg Gly Met Tyr Thr Tyr Leu Thr Gly Ser Ala Ser
785 790 795 800
Trp Leu Leu Leu Thr Gln Leu Thr Glu Val Tyr Gly Val Lys Gly Arg
805 810 815
Phe Gly Asp Leu Arg Leu Glu Pro Lys Leu Val Gln Ala Gln Phe Asp
820 825 830
Gly Ser Gly Glu Ala Ala Val Glu Thr Leu Phe Ala Gly Arg Met Leu
835 840 845
Arg Val Val Tyr Arg Asn Pro Gln Ala Ala Glu His Gly Gln Tyr Arg
850 855 860
Val Asp Ser Val Ser Leu Asn Gly Gln Ser Val Asp Phe Gln Asn Asp
865 870 875 880
Gly Ala Gly Cys Leu Ile Gly Arg Ser Leu Ile Glu Ala Leu Pro Ala
885 890 895
Asp Gly Val His Glu Leu Ile Val Thr Leu Gly Arg Asn Ile Ser
900 905 910
<210> 6
<211> 911
<212> PRT
<213> Artificial sequence ()
<400> 6
Met Gly Gln Lys Gly Trp Lys Phe Gln Gly Ile Val Gly Glu Phe Arg
1 5 10 15
Leu Glu Gln Pro Glu His Asn Ser Tyr Gln Tyr Phe Pro Leu Val Asn
20 25 30
Glu Ala Gly Met Met Ser Ala Val Thr Pro Asn Leu His Gly Glu Ile
35 40 45
Thr Ser Gly His Asn Thr Phe Leu Met Glu Pro Val Ser Ala Glu Ser
50 55 60
Leu His Asn Ser Lys Ala Ser Arg Asn Phe Trp Val Phe Ile Glu Gly
65 70 75 80
Tyr Gly Ala Trp Ser Val Ser Gly Asn Ser Ala Arg Gln Asn Ala Ala
85 90 95
Arg Phe Thr Gly Glu Glu Glu Arg Ser Ala Val Glu Ala Gly Phe Leu
100 105 110
Trp His Ala Val Thr Arg Glu Asn Glu Lys Ala Gly Leu Lys Ala Arg
115 120 125
Thr Val Ser Phe Val Pro Val Thr Asp Asp Lys Ile Glu Leu Met Arg
130 135 140
Val Thr Leu Thr Asn Thr Gly Asn Ala Pro Leu Lys Leu Thr Pro Thr
145 150 155 160
Ala Ala Ile Pro Leu Tyr Gly Arg Ser Ala Asn Asp Leu Arg Asp His
165 170 175
Arg His Val Thr Ser Leu Leu His Arg Ile Phe Thr Ser Glu Tyr Gly
180 185 190
Ile Glu Val Gln Pro Ala Leu Ser Phe Asp Glu Arg Gly His Arg Val
195 200 205
Asn Lys Val Thr Tyr Gly Val Phe Gly Ala Glu Ala Gly Gly Thr Ala
210 215 220
Pro Ala Gly Phe Phe Pro Val Thr Glu Asp Phe Ile Gly Glu Gly Gly
225 230 235 240
Ala Leu Asp Trp Pro Glu Ala Val Val Ala Asn Arg Glu Pro Asp Ala
245 250 255
Gln Ala Gly Thr Ala Val Glu Gly Tyr Glu Ala Val Gly Ala Leu Arg
260 265 270
Phe Ala Pro Val Glu Leu Ala Pro Gly Lys Ser Val Ser Tyr Val Val
275 280 285
Ala Met Val Ile Ser Gly Asp Arg Ile Asp Val Gly Arg Tyr Ala Ala
290 295 300
Asp Tyr Leu Ala Ala Gly Arg Phe Asp Ala Leu Leu Glu Gln Asn Arg
305 310 315 320
Ala Tyr Trp Arg Asp Lys Leu Asp Thr Val Arg Phe Ser Ser Gly Asp
325 330 335
Gly Glu Gln Asp Leu Trp Met Lys Trp Val Thr Leu Gln Pro Ile Leu
340 345 350
Arg Arg Leu Tyr Gly Asn Ser Phe Leu Pro Tyr His Asp Tyr Gly Arg
355 360 365
Gly Gly Arg Gly Trp Arg Asp Leu Trp Gln Asp Cys Leu Ala Leu Met
370 375 380
Val Met Glu Pro Ala Glu Val Arg His Leu Leu Leu Asn Asn Tyr Ala
385 390 395 400
Gly Val Arg Met Asp Gly Ser Asn Ala Thr Ile Ile Gly Ala Gly Pro
405 410 415
Gly Glu Phe Val Ala Asp Arg Asn Asn Ile Pro Arg Val Trp Met Asp
420 425 430
His Gly Ala Trp Pro Leu Met Thr Thr Leu Leu Tyr Leu His Gln Ser
435 440 445
Gly Asp Leu Gly Leu Leu Phe Gln Pro Gln Ser Tyr Phe Arg Asp Val
450 455 460
Phe Val Lys Arg Cys Arg Glu Arg Asp Ala Ser Trp Thr Pro Glu Gln
465 470 475 480
Gly Asn Lys Leu Leu Thr Ala Asp Gly Gln Ile Tyr Glu Gly Thr Ile
485 490 495
Leu Glu His Ile Leu Leu Gln Asn Ile Val Pro Phe Phe Asn Val Gly
500 505 510
Glu His Gly Asn Ile Lys Leu Glu Gly Ala Asp Trp Asn Asp Gly Leu
515 520 525
Asp Leu Ala Pro Glu Arg Gly Glu Ser Val Ala Phe Thr Ala Phe Tyr
530 535 540
Ala Ser Asn Leu Met Glu Leu Ser Glu Leu Leu Leu Glu Leu Gln Lys
545 550 555 560
Arg Thr Gly Lys Asp Ser Leu Asp Ile Ala Glu Glu Met Ala Leu Leu
565 570 575
Leu Asp Thr Leu Gly Lys Pro Ile Ser Tyr Asp Ser Ile Gln Glu Lys
580 585 590
Arg Ser Leu Leu Asp Arg Tyr Tyr Asp Ala Val Thr Pro Arg Val Ser
595 600 605
Gly Lys Lys Leu Leu Leu Asp Ile Arg Lys Val Ala Glu Asp Leu Lys
610 615 620
Arg Lys Ala Asp Trp Ala Val Ala His Leu Arg Gly Ser Glu Trp Ile
625 630 635 640
Gln Ser Lys Glu Gly Tyr Ala Trp Phe Asn Gly Tyr Tyr Asn Asn Asp
645 650 655
Gly Glu Arg Val Glu Gly Asp His Pro Asp Gly Val Arg Met Thr Leu
660 665 670
Thr Gly Gln Val Phe Ala Ile Met Gly Gly Val Ala Thr Asp Glu Gln
675 680 685
Thr Glu Lys Ile Ser Gln Ala Val Asn Arg Tyr Leu Lys Asp Glu Arg
690 695 700
Ile Gly Tyr Arg Leu Asn Ser Arg Phe Gly Gly Ile Gln Gln Asn Leu
705 710 715 720
Gly Arg Ala Phe Gly Phe Ala Phe Gly His Lys Glu Asn Gly Ala Met
725 730 735
Phe Ser His Met Thr Val Met Tyr Ala Asn Ala Leu Tyr Lys Arg Gly
740 745 750
Phe Val Gln Glu Gly Phe Glu Val Leu Asp Ser Ile Tyr Arg Leu Ser
755 760 765
Ala Asp Phe Glu Asn Ser Arg Ile Tyr Pro Gly Val Pro Glu Tyr Ile
770 775 780
Asn Glu Arg Gly Arg Gly Met Tyr Thr Tyr Leu Thr Gly Ser Ala Ser
785 790 795 800
Trp Leu Leu Leu Thr Gln Leu Thr Glu Val Tyr Gly Val Lys Gly Arg
805 810 815
Phe Gly Asp Leu Arg Leu Glu Pro Lys Leu Val Gln Ala Gln Phe Asp
820 825 830
Gly Ser Gly Glu Ala Ala Val Glu Thr Leu Phe Ala Gly Arg Met Leu
835 840 845
Arg Val Val Tyr Arg Asn Pro Gln Ala Ala Glu His Gly Gln Tyr Arg
850 855 860
Val Asp Ser Val Ser Leu Asn Gly Gln Ser Val Asp Phe Gln Asn Asp
865 870 875 880
Gly Ala Gly Cys Leu Ile Gly Arg Ser Leu Ile Glu Ala Leu Pro Ala
885 890 895
Asp Gly Val His Glu Leu Ile Val Thr Leu Gly Arg Asn Ile Ser
900 905 910
<210> 7
<211> 911
<212> PRT
<213> Artificial sequence ()
<400> 7
Met Gly Gln Lys Gly Trp Lys Phe Gln Gly Ile Val Gly Glu Phe Arg
1 5 10 15
Leu Glu Gln Pro Glu His Asn Ser Tyr Gln Tyr Phe Pro Leu Val Asn
20 25 30
Glu Ala Gly Met Met Ser Ala Val Thr Pro Asn Leu His Gly Glu Ile
35 40 45
Thr Ser Gly His Asn Thr Phe Leu Met Glu Pro Val Ser Ala Glu Ser
50 55 60
Leu His Asn Ser Lys Ala Ser Arg Asn Phe Trp Val Phe Ile Glu Gly
65 70 75 80
Tyr Gly Ala Trp Ser Val Ser Gly Asn Ser Ala Arg Gln Asn Ala Ala
85 90 95
Arg Phe Thr Gly Glu Glu Glu Arg Ser Ala Val Glu Ala Gly Phe Leu
100 105 110
Trp His Ala Val Thr Arg Glu Asn Glu Lys Ala Gly Leu Lys Ala Arg
115 120 125
Thr Val Ser Phe Val Pro Val Thr Asp Asp Lys Ile Glu Leu Met Arg
130 135 140
Val Thr Leu Thr Asn Thr Gly Asn Ala Pro Leu Lys Leu Thr Pro Thr
145 150 155 160
Ala Ala Ile Pro Leu Tyr Gly Arg Ser Ala Asn Asp Leu Arg Asp His
165 170 175
Arg His Val Thr Ser Leu Leu His Arg Thr Phe Thr Ser Glu Tyr Gly
180 185 190
Ile Glu Val Gln Pro Ala Leu Ser Phe Asp Glu Arg Gly His Arg Val
195 200 205
Asn Lys Val Thr Tyr Gly Val Phe Gly Ala Glu Ala Gly Gly Thr Ala
210 215 220
Pro Ala Gly Phe Phe Pro Val Thr Glu Asp Phe Ile Gly Glu Gly Gly
225 230 235 240
Ala Leu Asp Trp Pro Glu Ala Val Val Ala Asn Arg Glu Pro Asp Ala
245 250 255
Gln Ala Gly Thr Ala Val Glu Gly Tyr Glu Ala Val Gly Ala Leu Arg
260 265 270
Phe Ala Pro Val Glu Leu Ala Pro Gly Lys Ser Val Ser Tyr Val Val
275 280 285
Ala Met Val Ile Ser Gly Asp Arg Ile Asp Val Gly Arg Tyr Ala Ala
290 295 300
Asp Tyr Leu Ala Ala Gly Arg Phe Asp Ala Leu Leu Glu Gln Asn Arg
305 310 315 320
Ala Tyr Trp Arg Asp Lys Leu Asp Thr Val Arg Phe Ser Ser Gly Asp
325 330 335
Gly Glu Gln Asp Leu Trp Met Lys Trp Val Thr Leu Gln Pro Ile Leu
340 345 350
Arg Arg Leu Tyr Gly Asn Ser Phe Leu Pro Tyr His Asp Tyr Gly Arg
355 360 365
Gly Gly Arg Gly Trp Arg Asp Leu Trp Gln Asp Cys Leu Ala Leu Met
370 375 380
Val Met Glu Pro Ala Glu Val Arg His Leu Leu Leu Asn Asn Tyr Ala
385 390 395 400
Gly Val Arg Met Asp Gly Ser Asn Ala Thr Ile Ile Gly Ala Gly Pro
405 410 415
Gly Glu Phe Val Ala Asp Arg Asn Asn Ile Pro Arg Val Trp Met Asp
420 425 430
His Gly Ala Trp Pro Leu Met Thr Thr Leu Leu Tyr Leu His Gln Ser
435 440 445
Gly Asp Leu Gly Leu Leu Phe Gln Pro Gln Ser Tyr Phe Arg Asp Val
450 455 460
Phe Val Lys Arg Cys Arg Glu Arg Asp Ala Ser Trp Thr Pro Glu Gln
465 470 475 480
Gly Asn Lys Leu Leu Thr Ala Asp Gly Gln Ile Tyr Glu Gly Thr Ile
485 490 495
Leu Glu His Ile Leu Leu Gln Asn Ile Val Pro Phe Phe Asn Val Gly
500 505 510
Glu His Gly Asn Ile Lys Leu Glu Gly Ala Asp Trp Asn Asp Gly Leu
515 520 525
Asp Leu Ala Pro Glu Arg Gly Glu Ser Val Ala Phe Thr Ala Phe Tyr
530 535 540
Ala Ser Asn Leu Met Glu Leu Ser Glu Leu Leu Leu Glu Leu Gln Lys
545 550 555 560
Arg Thr Gly Lys Asp Ser Leu Asp Ile Ala Glu Glu Met Ala Leu Leu
565 570 575
Leu Asp Thr Leu Gly Lys Pro Ile Ser Tyr Asp Ser Ile Gln Glu Lys
580 585 590
Arg Ser Leu Leu Asp Arg Tyr Tyr Asp Ala Val Thr Pro Arg Val Ser
595 600 605
Gly Lys Lys Leu Leu Leu Asp Ile Arg Lys Val Ala Glu Asp Leu Lys
610 615 620
Arg Lys Ala Asp Trp Ala Val Ala His Leu Arg Gly Ser Glu Trp Ile
625 630 635 640
Gln Ser Lys Glu Gly Tyr Ala Trp Phe Asn Gly Tyr Tyr Asn Asn Asp
645 650 655
Gly Glu Arg Val Glu Gly Asp His Pro Asp Gly Val Arg Met Thr Leu
660 665 670
Thr Gly Gln Val Phe Ala Ile Met Gly Gly Val Ala Thr Asp Glu Gln
675 680 685
Thr Glu Lys Ile Ser Gln Ala Val Asn Arg Tyr Leu Lys Asp Glu Arg
690 695 700
Ile Gly Tyr Arg Leu Asn Ser Arg Phe Gly Gly Ile Gln Gln Asn Leu
705 710 715 720
Gly Arg Ala Phe Gly Phe Ala Phe Gly His Lys Glu Asn Gly Ala Met
725 730 735
Phe Ser His Met Thr Val Met Tyr Ala Asn Ala Leu Tyr Lys Arg Gly
740 745 750
Phe Val Gln Glu Gly Phe Glu Val Leu Asp Ser Ile Tyr Arg Leu Ser
755 760 765
Ala Asp Phe Glu Asn Ser Arg Ile Tyr Pro Gly Val Pro Glu Tyr Ile
770 775 780
Asn Glu Arg Gly Arg Gly Met Tyr Thr Tyr Leu Thr Gly Ser Ala Ser
785 790 795 800
Trp Leu Leu Leu Thr Gln Leu Thr Glu Val Tyr Gly Val Lys Gly Arg
805 810 815
Phe Gly Asp Leu Arg Leu Glu Pro Lys Leu Val Gln Ala Gln Phe Asp
820 825 830
Gly Ser Gly Glu Ala Ala Val Glu Thr Leu Phe Ala Gly Arg Met Leu
835 840 845
Arg Val Val Tyr Arg Asn Pro Gln Ala Ala Glu His Gly Gln Tyr Arg
850 855 860
Val Asp Ser Val Ser Leu Asn Gly Gln Ser Val Asp Phe Gln Asn Asp
865 870 875 880
Gly Ala Gly Cys Leu Ile Gly Arg Ser Leu Ile Glu Ala Leu Pro Ala
885 890 895
Asp Gly Val His Glu Leu Ile Val Thr Leu Gly Arg Asn Ile Ser
900 905 910

Claims (6)

1. A laminaria disaccharide phosphorylase mutant is characterized in that laminaria disaccharide phosphorylase with an amino acid sequence shown as SEQ ID NO.1 is subjected to iterative saturation mutation and/or random mutation to obtain laminaria disaccharide phosphorylase mutant with improved thermal stability; the amino acid sequences of the mutants are shown as SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5, SEQ ID NO.6 and SEQ ID NO. 7.
2. A gene encoding the laminarin phosphorylase mutant according to claim 1.
3. A vector or cell carrying the gene of claim 2, said cell being of a non-animal or plant variety.
4. A method for preparing laminarin by catalyzing starch at high temperature is characterized in that escherichia coli BL21 (DE 3) is taken as a host to respectively and recombinantly express starch phosphorylase from Thermotoga maritima; the enzyme preparation method comprises the steps of purifying and obtaining recombinant enzyme by using a glucosaccharase derived from paecilomyces lilacinus and an isoamylase derived from sulfolobus as well as the laminaria disaccharide phosphorylase mutant as claimed in claim 1, constructing an in-vitro multi-enzyme system, and catalyzing starch at high temperature to prepare laminaria disaccharide.
5. The in vitro multi-enzyme system of claim 4 further comprising divalent zinc ions, potassium phosphate, sodium acetate and HEPES buffer.
6. The method for preparing laminarin by using laminarin phosphorylase mutant in vitro multienzyme to catalyze starch is characterized in that the laminarin phosphorylase mutant in claim 1 is used as a catalyst in the in vitro multienzyme system, and other high temperature resistant enzymes are combined, so that the laminarin can be produced by catalyzing starch at high temperature.
CN201911329886.3A 2019-12-20 2019-12-20 Thallus laminariae disaccharide phosphorylase mutant with improved heat stability and application thereof Active CN113005104B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911329886.3A CN113005104B (en) 2019-12-20 2019-12-20 Thallus laminariae disaccharide phosphorylase mutant with improved heat stability and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911329886.3A CN113005104B (en) 2019-12-20 2019-12-20 Thallus laminariae disaccharide phosphorylase mutant with improved heat stability and application thereof

Publications (2)

Publication Number Publication Date
CN113005104A CN113005104A (en) 2021-06-22
CN113005104B true CN113005104B (en) 2023-04-18

Family

ID=76382882

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911329886.3A Active CN113005104B (en) 2019-12-20 2019-12-20 Thallus laminariae disaccharide phosphorylase mutant with improved heat stability and application thereof

Country Status (1)

Country Link
CN (1) CN113005104B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113621666A (en) * 2021-08-24 2021-11-09 山东大学 Method for biosynthesizing laminaribiose

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10304882A (en) * 1996-11-08 1998-11-17 Hayashibara Biochem Lab Inc Kojibiose phosphorylase, its production and use
CN109706200A (en) * 2017-10-26 2019-05-03 中国科学院天津工业生物技术研究所 A method of preparing laminaribiose

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7431172B2 (en) * 2018-04-23 2024-02-14 ダニスコ・ユーエス・インク Synthesis of glucans containing β-1,3 glycosidic bonds using phosphorylase enzymes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10304882A (en) * 1996-11-08 1998-11-17 Hayashibara Biochem Lab Inc Kojibiose phosphorylase, its production and use
CN109706200A (en) * 2017-10-26 2019-05-03 中国科学院天津工业生物技术研究所 A method of preparing laminaribiose

Also Published As

Publication number Publication date
CN113005104A (en) 2021-06-22

Similar Documents

Publication Publication Date Title
CN110373397B (en) Nicotinamide phosphoribosyl transferase mutant and application thereof
CN111394330B (en) Cyclodextrin glucosyltransferase mutant T168A and preparation method thereof
CN112795606B (en) Enzymatic synthesis method of beta-nicotinamide mononucleotide
CN111254129B (en) Polyphosphate kinase mutant and application thereof
CN110592059B (en) Maltooligosyl trehalose synthase mutant
CN112877307B (en) Amino acid dehydrogenase mutant and application thereof
CN113122519B (en) Heat-resistant glucosamine phosphate phosphatase mutant and application thereof
CN113265382B (en) Polyphosphate kinase mutant
CN111394292A (en) Multi-way composite neuraminic acid-producing bacillus subtilis and application thereof
CN113005104B (en) Thallus laminariae disaccharide phosphorylase mutant with improved heat stability and application thereof
CN113025592B (en) High-performance polyphosphate kinase mutant and application thereof
CN113106080B (en) Nicotinamide phosphoribosyl transferase mutant and application thereof
CN113583997A (en) Phosphatase mutant and application thereof in catalyzing maltodextrin to prepare mannose
CN110904088B (en) High-temperature-resistant D-psicose3-epimerase, mutant and application thereof
CN109576240B (en) Amylosucrase mutant and preparation method and application thereof
CN113046335A (en) Glucose 6-phosphate dehydrogenase mutant with bionic coenzyme preference and application thereof
CN112301011B (en) Glycosyltransferase variants and uses thereof
CN112921025B (en) Mutant of epimerase, coding gene, amino acid sequence and application thereof
US11001825B2 (en) Thermophilic L-asparaginase mutant and screening and fermentation methods thereof
CN112680482B (en) Biological preparation method of mannitol
CN113005160B (en) Method for preparing cellobiose by starch conversion
CN114381446B (en) Heat-resistant acid-resistant arabinosidase gene, and expression protein, recombinant vector, recombinant bacterium and application thereof
CN115948355A (en) NADPH oxidase mutant and application thereof
KR20220096207A (en) Tagatose 6-phosphatase with high substrate specificity and use of the same
CN116875578A (en) Triplet fusion enzyme, preparation method thereof and method for preparing nicotinamide mononucleotide by using triplet fusion enzyme

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant